Video
See 
in action.
Real patients, real clinical conversations, and AI Sync working on live data. No mockups, no narration over slides.
One patient, start to finish: from the first text link to a couple reviewing their results together, all in plain language.
Transcript
Narrator: Igentify empowers a new standard of patient engagement, combining digital health innovation with personalized medicine, from onboarding to results.
Narrator: Meet Maya. She's planning to start a family, and her doctor recommended a carrier screening test. Maya receives a link to begin the onboarding process, designed to educate her about the test and guide her every step of the way.
Narrator: Maya begins her journey by completing an app-based questionnaire, a simple and intuitive way to share the information her care team needs. She can also select the language she feels most comfortable with, ensuring the entire experience is clear, accessible, and personalized.
Narrator: Next, Maya watches a personalized education video. It's dynamically created based on her responses, giving her clear explanations about genetics and the purpose of the test, tailored specifically to her.
Digital advisor: The purpose of this test is to identify the possibility of having a child affected by a severe genetic condition.
Narrator: Once Maya feels confident and informed, she simply signs the acknowledgment form, all within the platform. When the results are ready, Maya receives a personalized video that explains her results and the next steps. If the screening was done as a couples test, both partners receive a paired video that walks them through their combined results and any reproductive risks.
Digital advisor: We have calculated your chance of having an affected child for each autosomal recessive condition based on available data and any ancestry information you have provided. Because you were not found to be carriers for the same genetic condition, the risk of having an affected child is significantly reduced compared to couples who are both carriers for the same genetic condition. In such cases, and according to commonly used guidelines, no follow-up testing is recommended.
Narrator: They also receive a detailed consult note. This end-to-end flow ensures that every patient receives personalized, clear, and supportive communication throughout their journey. With Igentify, it is fully adaptable to any clinical indication, within or outside of genetics.
Patient Engagement
Two moments, up close.
The same experience, zoomed in: how a patient learns why she's eligible, and how a result is delivered with nuance.
Transcript
Hi, Emma. I'm Lisa, your digital assistant here at Igentify. Your doctor, Dr. Sean Thomas Williams, wanted to ensure you have access to important tools that can help you understand your cancer risk.
Oncogenetic testing, also known as genetic testing for cancer risk, looks for specific changes in your genes, called pathogenic variants, that could increase your risk for certain types of cancer.
Emma, I understand that your mother was diagnosed with breast cancer and that you have Ashkenazi Jewish ancestry. Based on this information, you are eligible for genetic testing under the current medical guidelines.
There are a few different tests that may be relevant for you. The main difference between them is the scope, specifically the number of genes tested and the range of cancer risks assessed. At the end of this session, we'll show you the testing options available to you and ask you to choose the one you'd like to proceed with. Ready to continue?
Transcript
Hi, Emma. My name is Lisa, and I'm Igentify's digital assistant. Your Igentify ONCO test results are ready and were found to be negative. I'll be happy to explain these results to you.
A negative result means no harmful genetic variants were identified in the two genes that were tested. These genes are known to be associated with an increased risk of developing breast cancer.
While no genetic changes were found, it's important to understand that a negative result doesn't eliminate all cancer risks. Based on your family history, your cancer risk may still be higher than that of the general population. In addition to routine screening, extra monitoring may be recommended for you to stay proactive about your health.
Thank you, Emma. I'll be available to answer your questions and review current screening guidelines and recommendations in the chat.
The Digital Advisor
Not a chatbot. A real clinical conversation.
The same advisor collects family history, answers questions, and reaches out proactively, in the patient's own language.
Transcript
Lisa: Hi, Emma. I'm Lisa, your digital health assistant. I'll walk you through some simple questions to help gather your family health history. It won't take long, about five to ten minutes. Shall we begin?
Emma: Sure. Yes.
Lisa: Great. Do you have any siblings?
Emma: Yes, I have one brother and two sisters.
Lisa: What is your mother's family origin?
Emma: She is Ashkenazi Jewish.
Lisa: Thank you for sharing. And what is your father's family origin?
Emma: His family is from China.
Lisa: Has anyone in your family been diagnosed with cancer?
Emma: Yes, my mother.
Lisa: I'm sorry to hear that. What type of cancer did she have?
Emma: Breast cancer.
Lisa: Do you know how old she was when she was diagnosed?
Emma: Let's see, I was 10, so she must have been about 40.
Transcript
Caller: Hello? Hello, Emma? This is a health services call on behalf of Dr. Sean Thomas. Is now a good time to talk?
Emma: Ah, yes. Pero hablo español.
Caller: Por supuesto, hablemos en español. Your doctor has asked us to check if you may be eligible for genetic screening tests that can help assess your risk for certain types of cancers.
Transcript
Lisa: Hi. Hello. I'm Lisa, Igentify Oncotest's digital assistant. How can I assist you today with questions about hereditary cancer genetic testing?
Patient: If the test comes back negative, does this ensure I will not have breast cancer?
Lisa: It's understandable to have concerns about your health. A negative test result means no pathogenic variants related to hereditary cancer were found, but it does not guarantee that you won't develop breast cancer in the future. It is still important to follow routine screening based on personal and family history. Would you like more information about screening recommendations?
Patient: No, thank you. I am good for now.
Lisa: You're welcome. If you have any further questions in the future about hereditary cancer screening, feel free to reach out. Take care.
AI Sync
Working on real clinical data.
Watch AI Sync read, validate, and normalize fragmented clinical data before it becomes a downstream problem.
Transcript
Healthcare organizations deal with massive volumes of data, from lab results to clinical summaries and other healthcare documents. Each comes in a different format, and turning it into usable, structured data is time consuming and prone to error.
Meet AI Sync by Igentify, your smart engine for turning documents into usable data. It transforms unstructured information into structured, standardized data. AI Sync is designed to interpret the context, structure, and meaning of clinical information. Unlike traditional OCR, it doesn't just extract text. It validates data, flags at-risk cases for human review, and detects inconsistencies in real time.
Once validated, AI Sync sends clean data directly into your existing systems with minimal IT effort. Built for scale, AI Sync can process tens of thousands, even millions of documents with no compromise in speed or accuracy. And once your data is structured, you can search across it, explore trends, and identify meaningful patterns that support research, reporting, and decision making.
The result? Faster processing, fewer errors, and more reliable operations across your organization. Already operating in clinical production environments, AI Sync replaces hundreds of hours of manual data handling every month, reducing errors, shortening turnaround times, and improving data quality. AI Sync: ingest, validate, standardize, deliver.
Want to see it on your own data?
We'll walk your team through a patient journey and AI Sync, mapped to your workflows.